Adjusting Atrial Sensitivity to Discriminate VT from SVT
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current implantable cardiac stimulation devices often deliver inappropriate high voltage shocks due to misidentification of supraventricular tachycardia (SVT) as ventricular tachycardia (VT), leading to unnecessary and painful therapies, as they fail to accurately distinguish between the two conditions when the ventricular rate exceeds the atrial rate.
Innovation Solution
The device selectively adjusts atrial channel detection parameters such as post-ventricular atrial blanking (PVAB) interval or atrial channel sensitivity to reassess the atrial rate, ensuring it is equal to the ventricular rate before delivering therapy, employing morphological analysis and AV association stability to differentiate between SVT and VT.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If the device immediately delivers high voltage shock therapy when ventricular rate exceeds VT threshold while atrial rate is underestimated, then rapid therapy delivery is achieved, but inappropriate therapy is delivered
Solution Approach 1:
The device performs preliminary actions by adjusting atrial channel detection parameters (PVAB interval, sensitivity) before delivering therapy to obtain a more accurate atrial rate. This preliminary detection phase ensures that the arrhythmia type is correctly identified before committing to high voltage shock therapy, preventing inappropriate treatment while maintaining rapid response capability.
Solution Approach 2:
The device uses feedback mechanisms by comparing the initially detected atrial rate with the ventricular rate, and if discrepancy is found, re-detecting the atrial rate with adjusted parameters. This feedback loop ensures accurate discrimination between SVT and VT by continuously verifying the atrial rate measurement against the ventricular rate relationship, thereby improving reliability without sacrificing therapy delivery speed.
2Device complexity
If the device uses fixed atrial channel detection parameters, then device complexity is minimized, but measurement precision of atrial rate deteriorates
Solution Approach 1:
The device implements dynamic adjustment of atrial channel detection parameters (PVAB interval and sensitivity) based on the detected arrhythmia conditions. When ventricular tachycardia is suspected and atrial rate appears underestimated, the device dynamically modifies these parameters to improve measurement precision. This dynamic approach maintains simple fixed parameters during normal operation while enabling precise measurement when needed, balancing complexity and accuracy.
Solution Approach 2:
The device changes detection parameters (PVAB interval duration, atrial channel sensitivity threshold) selectively based on the arrhythmia detection context. By modifying these parameters only when VT/SVT discrimination is required and atrial rate underestimation is suspected, the device achieves high measurement precision without permanently increasing device complexity. The parameter changes are conditional and reversible, maintaining operational simplicity.
Data Source
AI summary
Techniques are described for discriminating ventricular tachycardia (VT) from supraventricular tachycardia (SVT) in circumstances when the ventricular rate exceeds the atrial rate (i.e. V>A). In one example, an initial atrial rate is detected while employing adjustable atrial channel detection parameters that can affect the detection of the true atrial rate—such as a post-ventricular atrial blanking (PVAB) interval or an atrial channel sensitivity level. If the ventricular rate exceeds a VT rate zone threshold with V>A, the device does not immediately deliver high voltage shock therapy as done in other devices. Rather, the device instead selectively adjusts the atrial channel detection parameter(s) to determine if the true atrial rate is equal to the ventricular rate. If so, then such is an indication that the arrhythmia might be SVT rather than VT and various discrimination procedures are employed to distinguish SVT from VT before therapy is delivered.